Naloxegol functions as a peripherally acting mu-opioid receptor antagonist in tissues such as the gastrointestinal tract, thereby decreasing the constipating effects of opioids.
Glyxambi is adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
A Southern diet included added fats, fried food, and processed meats raises the risk for acute coronary heart disease.
Clinicians should educate new mothers on various aspects of infant care.
Vitamin D did not improve bone and muscle outcomes in postmenopausal women.